Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:SILK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSILKSilk Road Medical$27.49$27.31$6.08▼$27.51$1.12B1.531.20 million shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSILKSilk Road Medical0.00%0.00%0.00%0.00%+36.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSILKSilk Road Medical0.4338 of 5 stars0.80.00.04.30.60.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSILKSilk Road Medical 1.67Reduce$27.500.04% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSILKSilk Road Medical$177.13M6.31N/AN/A$3.88 per share7.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSILKSilk Road Medical-$55.74M-$1.37N/AN/AN/A-29.53%-37.30%-21.57%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSILKSilk Road MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSILKSilk Road Medical0.497.636.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSILKSilk Road MedicalN/AInsider OwnershipCompanyInsider OwnershipSILKSilk Road Medical3.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableSILKSilk Road Medical41040.63 million37.91 millionOptionableSILK HeadlinesRecent News About These CompaniesThree Andritz spunlace lines for Alear Silk RoadApril 25, 2025 | innovationintextiles.comANDRITZ To Supply Three Spunlace Lines To Alear Silk Road New Materials, ChinaApril 25, 2025 | textileworld.com2,200-year-old grave in China contains 'Red Princess of the Silk Road' whose teeth were painted with a toxic substanceMarch 12, 2025 | msn.comXinjiang a front-runner in BRI medical cooperationMarch 7, 2025 | chinadaily.com.cnEndologix Appoints Andrew Davis as Chief Commercial OfficerMarch 3, 2025 | businesswire.comChina’s Belt and Road Initiative: The art of exploiting threats and opportunitiesFebruary 21, 2025 | tehrantimes.comBoston Scientific ramped up headcount, real estate footprint in 2024February 21, 2025 | bizjournals.comTrump pardons Silk Road founder Ross Ulbricht for online drug schemeJanuary 23, 2025 | reuters.comTrump pardons Ross Ulbricht, creator of online black market for illegal drugsJanuary 23, 2025 | msn.comTrump pardons founder of Silk Road websiteJanuary 23, 2025 | msn.comSilk Road founder Ross Ulbricht went to prison a libertarian hero. Trump just set him free.January 22, 2025 | msn.comTrump pardons online drug marketplace Silk Road founder, Austin native Ross UlbrichtJanuary 22, 2025 | msn.comWho Is Ross Ulbricht? What To Know About ‘Silk Road’ Drug Marketplace Founder Pardoned By Trump.January 22, 2025 | msn.comTrump pardons Ross Ulbricht, founder of online drug market Silk RoadJanuary 22, 2025 | msn.comTrump Pardons Creator of Silk Road Drug MarketplaceJanuary 22, 2025 | nytimes.comChinese, Pakistani firms sign $250m MoUsJanuary 19, 2025 | tribune.com.pkMoUs worth $250m signed with Chinese medical companiesJanuary 19, 2025 | dawn.comPakistani, Chinese companies ink $250mn MoUs to boost medical sectorJanuary 18, 2025 | brecorder.comPakistani, Chinese companies ink $250 million MoUs to boost medical sectorJanuary 18, 2025 | business-standard.comChinese, Pakistani companies reach $250 mln MoUs on medical equipmentJanuary 18, 2025 | app.com.pkSILK Company DescriptionsSilk Road Medical NASDAQ:SILKSilk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/28 - 05/02 Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Why Spotify Stock Still Has Room to Run in 2025 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
